Clinical trials in Temple, TX

17 recruiting studies have a site in or near Temple, TX, Texas.

Top conditions here

All conditions

Showing 17 of 17 studies

RecruitingPhase 2NCT06317662

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

Sponsor: National Cancer Institute (NCI)

Austin, TX · Corpus Christi, TX · Dallas, TX · +112 more sites

RecruitingPhase 3NCT06819878

A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

Sponsor: Hoffmann-La Roche

Arlington, TX · El Paso, TX · Georgetown, TX · +92 more sites

RecruitingNot applicableNCT07574593

NORM-HF Pivotal Study

Sponsor: Foundry Innovation & Research 1, Limited (FIRE1)

Dallas, TX · Plano, TX · Round Rock, TX · +22 more sites

RecruitingPhase 3NCT06023589

A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma

Sponsor: AstraZeneca

Coppell, TX · Dallas, TX · Frisco, TX · +27 more sites

RecruitingPhase 3NCT06307652

Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function

Sponsor: AstraZeneca

Allen, TX · Amarillo, TX · +163 more sites

RecruitingPhase 3NCT07222800

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Sponsor: Pfizer

Abilene, TX · Amarillo, TX · Beaumont, TX · +251 more sites

RecruitingNot applicableNCT06812533

Alleviant ALLAY-HFrEF Study

Sponsor: Alleviant Medical, Inc.

Abilene, TX · Austin, TX · +37 more sites

RecruitingPhase 3NCT06982521

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

Sponsor: Relay Therapeutics, Inc.

Austin, TX · Dallas, TX · +49 more sites

RecruitingNot applicableNCT06906627

Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)

Sponsor: Duke University

Temple, TX · +6 more sites

RecruitingPhase 3NCT04293562

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Sponsor: Children's Oncology Group

Austin, TX · Corpus Christi, TX · Dallas, TX · +183 more sites

RecruitingPhase not listedNCT05489705

A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)

Sponsor: Bristol-Myers Squibb

Dallas, TX · Houston, TX · +57 more sites

RecruitingPhase 3NCT07567001

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

Sponsor: Novo Nordisk A/S

Amarillo, TX · Austin, TX · Conroe, TX · +203 more sites

RecruitingPhase 3NCT05812807

Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

Sponsor: Alliance for Clinical Trials in Oncology

Baytown, TX · Conroe, TX · Cypress, TX · +825 more sites

RecruitingPhase 2NCT06948448

A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer

Sponsor: Ono Pharmaceutical Co., Ltd.

Temple, TX · +10 more sites

RecruitingPhase not listedNCT07327489

Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)

Sponsor: Elephas

Forth Worth, TX · Temple, TX · +6 more sites

RecruitingPhase not listedNCT04739072

Minimal Residual Disease Assessment in Patients With Colorectal Cancer, the MiRDA-C Study

Sponsor: M.D. Anderson Cancer Center

Dallas, TX · Houston, TX · +7 more sites

RecruitingNot applicableNCT06444841

Paper-Based and Smartphone-Based Memory Supports

Sponsor: Baylor University

Austin, TX · Temple, TX · Waco, TX

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.